Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SML Genetree
Seoul, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
SML Genetree has successfully developed and commercialized several FDA EUA-approved and Korea MFDS-approved multiplex molecular diagnostic products, covering infectious, respiratory, and gastrointestinal diseases, and continues pipeline innovation with NGS and POCT technology. There are no active interventional clinical trials registered for their products[1][3][4][5][6].
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Diagnostic devicePCR-based diagnosticsNext-generation sequencing (NGS) diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
Samkwang Medical FoundationKorean conglomerates (POCT device development)
Beyond the preview
Go deeper on SML Genetree.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SML Genetree.